Oragenics (OGEN) Change in Inventory (2010 - 2016)
Oragenics' (OGEN) quarterly Change in Inventory came in at -$80027.0 in Q1 2016, down 28.72% YoY from -$112266.0 in Q2 2015, and down 460.6% on a QoQ basis from $22193.0 in Q4 2015.
Oragenics (OGEN) Change in Inventory (2010 - 2016) Analysis & Trends
Oragenics (OGEN) has 7 years of Change in Inventory data on file, last reported at -$80027.0 in Q1 2016.
- Quarterly Change in Inventory fell 28.72% year-over-year to -$80027.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was -$135534.0 (down 221.96% YoY) and the FY2015 annual result came in at -$117680.0, down 178.03% from the prior year.
- Change in Inventory fell to -$80027.0 in Q1 2016, from $22193.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $305070.0 in Q4 2013 to a low of -$155771.0 in Q4 2012.
- A 5-year average of -$13771.2 and a median of -$26908.0 in 2014 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2012 — Change in Inventory tumbled 1639.54% — and 2013, when it surged 295.85%.
- Tracing OGEN's Change in Inventory over 5 years: stood at -$155771.0 in 2012, then surged by 295.85% to $305070.0 in 2013, then plunged by 42.53% to $175329.0 in 2014, then plunged by 87.34% to $22193.0 in 2015, then slumped by 460.6% to -$80027.0 in 2016.
- The last three Change in Inventory figures came in at -$80027.0 (Q1 2016), $22193.0 (Q4 2015), and -$64758.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -80,027.00 |
| Mar 31, 2016 | -80,027.00 |
| Dec 31, 2015 | 22,193.00 |
| Dec 31, 2015 | 22,193.00 |
| Sep 30, 2015 | -64,758.00 |
| Sep 30, 2015 | -64,758.00 |
| Jun 30, 2015 | -12,942.00 |
| Jun 30, 2015 | -12,942.00 |
| Mar 31, 2015 | -62,173.00 |
| Mar 31, 2015 | -62,173.00 |
| Dec 31, 2014 | 175,329.00 |
| Dec 31, 2014 | 175,329.00 |
| Sep 30, 2014 | 24,885.00 |
| Sep 30, 2014 | 24,885.00 |
| Jun 30, 2014 | -26,908.00 |
| Jun 30, 2014 | -26,908.00 |
| Mar 31, 2014 | -22,500.00 |
| Mar 31, 2014 | -22,500.00 |
| Dec 31, 2013 | 305,070.00 |
| Dec 31, 2013 | 305,070.00 |